Skip to main content
Premium Trial:

Request an Annual Quote

GSK Licenses Ingenuity s Pathway Database

NEW YORK, Sept. 22 (GenomeWeb News) - Ingenuity Systems said today that GlaxoSmithKline has licensed part of its Pathways Knowledge Base database.

Ingenuity said that GSK would use the database - which maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases - as part of its internal computational genomics effort.

Further details about the licensing agreement were not provided.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.